Johnson & Johnson

Holdings as of Sep 30, 2026 · filed Oct 26, 2026

$761691304
Portfolio value
15
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Protagonist Therapeutics Inc $345065393 45.30% — Held
2 Nanobiotix $175238107 23.01% — Held
3 Meiragtx Hldgs Plc $73051704 9.59% — Held
4 Rapport Therapeutics Inc $59959771 7.87% — Held
5 Contineum Therapeutics Inc $26560502 3.49% — Held
6 Cerebras Systems Inc $22854495 3.00% +75063 +140.08%
7 Xencor Inc $18664147 2.45% — Held
8 Legend Biotech Corp $16202116 2.13% — Held
9 Fate Therapeutics Inc $8008382 1.05% — Held
10 Cvrx Inc $7043507 0.92% — Held
11 Procept Biorobotics Corp $6521649 0.86% — Held
12 Neumora Therapeutics Inc. $1102639 0.14% — Held
13 Vor Biopharma Inc $1025207 0.13% — Held
14 Standard Biotools Inc $231043 0.03% — Held
15 Adicet Bio Inc $162642 0.02% — Held

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.